查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1656105

實現彈性醫藥供應鏈的技術

Technologies Enabling Resilient Pharmaceutical Supply Chains
出版日期: | 出版商: Frost & Sullivan | 英文 43 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

以人工智慧為基礎的技術改變了醫藥供應鏈網路

本研究的目的是回顧新興的變革性技術解決方案，以重新設計醫藥供應鏈流程並為模型引入更高的彈性、透明度和回應能力。

研究回答了以下問題：大型製藥供應鏈如今必須面對哪些新挑戰？新科技如何提高透明度和彈性？有哪些技術解決方案可以實現醫藥供應鏈中主要相關人員之間的連結和溝通？鑑於最近的全球經濟衝擊，製藥公司可以部署哪些新的技術應用策略來使其供應鏈更快、更有效率？管理人員如何釋放與科技公司的供應商協同效應，讓製藥公司從開發更強大、一體化的醫藥供應協同效應模式中獲益？該領域主要企業的財務資源、技術準備和策略合作將如何影響醫藥供應鏈的發展和潛在成功？

目錄

戰略問題

  • 成長為何變得越來越艱難？
  • The Strategic Imperative 8（TM）
  • 三大策略挑戰對實現彈性醫藥供應鏈的技術的影響
  • 成長機會推動Growth Pipeline Engine（TM）™
  • 調查方法

成長機會分析

  • 分析範圍
  • 介紹
  • 分割

成長要素

  • 成長動力
  • 成長抑制因素

利用科技：醫藥供應鏈管理的新時代

  • 從製造商到批發商
  • 從批發商到藥局
  • 從藥局到患者

醫藥供應鏈創新新前景

  • 醫藥供應鏈中的關鍵參與企業

相關人員如何影響醫藥供應鏈的效率

  • 資金籌措分析
  • 重要夥伴關係與收購（2021-2024）

確保藥品分銷的可近性和安全性

  • 製造商到批發商：視角
  • 從批發商到藥局：視角
  • 藥局到患者：一個視角

醫藥供應鏈中的成長機會領域

  • 成長機會1：物聯網追蹤與監控
  • 成長機會二：區塊鏈帶來更高的透明度和可追溯性
  • 成長機會三：資料分析與以人工智慧為基礎的決策

後續步驟Next steps

  • 成長機會的好處和影響
  • 後續步驟Next steps
  • 免責聲明
簡介目錄
Product Code: DB13

AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network

This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience, transparency, and responsiveness into the model.

The study answers the following questions: What are some new challenges big pharma's supply chains must address today? How can emerging technologies help lead the way in transparency and resilience? How do different technological solutions allow connectivity and communication among important pharmaceutical supply chain stakeholders? Given the recent global economic shocks, what new technology application strategies can pharmaceutical companies deploy to make their supply chains more responsive and efficient? How can managers implement supplier synergies with technology companies and pharmaceutical companies benefit from formulating a more solid and integrated model for the pharmaceutical industry's supply chain? How do the funding, technical readiness, and strategic collaborations of key companies in this field influence the development and potential success of the pharmaceutical supply chain?

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Technologies Enabling Resilient Pharmaceutical Supply Chains
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Introduction
  • Segmentation

Growth Generator

  • Growth Drivers
  • Growth Restraints

Harnessing Technology: A New Era in Pharmaceutical Supply Chain Management

  • Manufacturers to Wholesalers
  • Wholesalers to Pharmacies
  • Pharmacies to Patients

Emerging Innovation Landscape for the Pharmaceutical Supply Chain

  • Key Pharmaceutical Supply Chain Participants

Impact of Stakeholders on Pharmaceutical Supply Chain Efficiency

  • Funding Analysis
  • Key Partnerships and Acquisitions, 2021-2024

Ensuring Access and Safety in Drug Distribution

  • Manufacturers to Wholesalers-Outlook
  • Wholesalers to Pharmacies-Outlook
  • Pharmacies to Patients-Outlook

Growth Opportunity Universe in the Pharmaceutical Supply Chain

  • Growth Opportunity 1: IoT-enabled Tracking and Monitoring
  • Growth Opportunity 2: Blockchain for Enhanced Transparency and Traceability
  • Growth Opportunity 3: Data Analytics and AI-driven Decision-making

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer